On the public citation graph

Elevated serum interferon‐α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty‐six months of therapy

https://doi.org/10.1002/art.24555
0 signed · 165 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1529-0131(200010)43:10<2368::aid-anr26>3.0.co;2-8openalex-snapshot
TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications
inferredcites →https://doi.org/10.1002/art.10566openalex-snapshot
Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis
inferredcites →https://doi.org/10.1002/art.10924openalex-snapshot
Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence
inferredcites →https://doi.org/10.1002/art.1780180410openalex-snapshot
Antibody levels to parainfluenza, rubella, measles, and influenza a virus in children with polymyositis
inferredcites →https://doi.org/10.1002/art.1780250407openalex-snapshot
Serum interferon levels in patients with systemic lupus erythematosus
inferredcites →https://doi.org/10.1002/art.1780291109openalex-snapshot
PREVALENCE OF COXSACKIE B VIRUS ANTIBODIES IN PATIENTS WITH JUVENILE DERMATOMYOSITIS
inferredcites →https://doi.org/10.1002/art.1780381019openalex-snapshot
Lack of detection of enteroviral rna or bacterial dna in magnetic resonance imaging–directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis
inferredcites →https://doi.org/10.1002/art.1780400822openalex-snapshot
New‐onset juvenile dermatomyositis. Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis
inferredcites →https://doi.org/10.1002/art.20998openalex-snapshot
Activation of the type I interferon system in primary Sjögren's syndrome: A possible etiopathogenic mechanism
inferredcites →https://doi.org/10.1002/art.21031openalex-snapshot
Activation of the interferon‐α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease
inferredcites →https://doi.org/10.1002/art.21068openalex-snapshot
History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry
inferredcites →https://doi.org/10.1002/art.21890openalex-snapshot
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti–RNA binding protein autoantibodies
inferredcites →https://doi.org/10.1002/art.22216openalex-snapshot
Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians
inferredcites →https://doi.org/10.1002/art.22928openalex-snapshot
Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis
inferredcites →https://doi.org/10.1002/art.23062openalex-snapshot
Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanercept
inferredcites →https://doi.org/10.1002/art.23191openalex-snapshot
Serum type I interferon activity is dependent on maternal diagnosis in anti‐SSA/Ro–positive mothers of children with neonatal lupus
inferredcites →https://doi.org/10.1002/art.23299openalex-snapshot
Persistent association of nailfold capillaroscopy changes and skin involvement over thirty‐six months with duration of untreated disease in patients with juvenile dermatomyositis
inferredcites →https://doi.org/10.1002/art.23613openalex-snapshot
Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patients
inferredcites →https://doi.org/10.1002/art.23728openalex-snapshot
The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon‐α activity and low tumor necrosis factor α levels in patients with lupus
inferredcites →https://doi.org/10.1006/clim.1998.4675openalex-snapshot
Association among SomaticHPRTMutant Frequency, Peripheral Blood T-Lymphocyte Clonality, and Serologic Parameters of Disease Activity in Children with Juvenile Onset Dermatomyositis
inferredcites →https://doi.org/10.1016/0198-8859(91)90085-nopenalex-snapshot
Molecular genetic studies of major histocompatibility complex genes in children with Juvenile dermatomyositis: Increased risk associated with HLA-DQA1∗0501
inferredcites →https://doi.org/10.1016/j.clim.2006.05.011openalex-snapshot
MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement
inferredcites →https://doi.org/10.1016/s0002-9440(10)61689-6openalex-snapshot
Plasmacytoid Dendritic Cells (Natural Interferon- α/β-Producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions
inferredcites →https://doi.org/10.1016/s0022-3476(05)81905-5openalex-snapshot
Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin
inferredcites →https://doi.org/10.1016/s0140-6736(08)60955-1openalex-snapshot
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
inferredcites →https://doi.org/10.1016/s0140-6736(87)92271-9openalex-snapshot
DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION
inferredcites →https://doi.org/10.1038/sj.gene.6364408openalex-snapshot
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
inferredcites →https://doi.org/10.1056/nejm197907053010102openalex-snapshot
Immune Interferon in the Circulation of Patients with Autoimmune Disease
inferredcites →https://doi.org/10.1073/pnas.0408506102openalex-snapshot
Cross-regulation of TNF and IFN-α in autoimmune diseases
inferredcites →https://doi.org/10.1089/107999099313901openalex-snapshot
Failure to Detect Antiviral Activity in Serum and Plasma of Healthy Individuals Displaying High Activity in ELISA for IFNWOLFRAM alpha beta and IFNral
inferredcites →https://doi.org/10.1093/rheumatology/ken038openalex-snapshot
Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset
inferredcites →https://doi.org/10.1111/j.1462-5822.2006.00716.xopenalex-snapshot
Interferon signalling network in innate defence
inferredcites →https://doi.org/10.1136/ard.2007.070359openalex-snapshot
Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients
inferredcites →https://doi.org/10.1136/ard.2007.077974openalex-snapshot
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
inferredcites →https://doi.org/10.1186/1471-2172-9-43openalex-snapshot
Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
inferredcites →https://doi.org/10.2119/2006-00085.baechleropenalex-snapshot
An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity
inferredcites →https://doi.org/10.4049/jimmunol.168.8.4154openalex-snapshot
Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4663953openalex-extracted
An Unconventional Mechanism of IL-1β Secretion that Requires Type I IFN in SLE Monocytes
inferred← citeshttps://doi.org/10.1001/archdermatol.2011.49openalex-snapshot
Double Trouble
inferred← citeshttps://doi.org/10.1001/archneurol.2012.465openalex-snapshot
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins
inferred← citeshttps://doi.org/10.1002/acr.20269openalex-snapshot
Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositis
inferred← citeshttps://doi.org/10.1002/art.27529openalex-snapshot
Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells
inferred← citeshttps://doi.org/10.1002/art.34659openalex-snapshot
Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course
inferred← citeshttps://doi.org/10.1002/art.38038openalex-snapshot
Brief Report: Interferon‐α Induction and Detection of Anti‐Ro, Anti‐La, Anti‐Sm, and Anti‐RNP Autoantibodies by Autoantigen Microarray Analysis in Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1002/art.40800openalex-snapshot
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features
inferred← citeshttps://doi.org/10.1002/art.41625openalex-snapshot
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies
inferred← citeshttps://doi.org/10.1002/jsp2.70095openalex-snapshot
Plasma Pro‐ and Anti‐Inflammatory Cytokines in an Observational Chronic Low Back Pain Cohort
inferred← citeshttps://doi.org/10.1002/mus.21669openalex-snapshot
Immunopathogenesis of juvenile dermatomyositis
inferred← citeshttps://doi.org/10.1007/978-3-031-60855-1_20openalex-snapshot
Markers of Autoimmune Rheumatic Diseases
inferred← citeshttps://doi.org/10.1007/978-3-642-34728-3_7openalex-snapshot
Dermatomyositis
inferred← citeshttps://doi.org/10.1007/978-981-19-5595-2_5openalex-snapshot
Plasmacytoid Dendritic Cells in Autoimmunity
inferred← citeshttps://doi.org/10.1007/s00296-010-1763-0openalex-snapshot
The association between dermatomyositis and papillary thyroid cancer: a case report
inferred← citeshttps://doi.org/10.1007/s10067-023-06645-1openalex-snapshot
Potential relevance of type I interferon-related biomarkers for the management of polygenic autoimmune rheumatic diseases with childhood onset
inferred← citeshttps://doi.org/10.1007/s10753-026-02469-8openalex-snapshot
Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1007/s10875-016-0359-1openalex-snapshot
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
inferred← citeshttps://doi.org/10.1007/s11926-011-0166-xopenalex-snapshot
Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon
inferred← citeshttps://doi.org/10.1007/s11926-011-0167-9openalex-snapshot
Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1007/s11926-015-0543-yopenalex-snapshot
Immunological Biomarkers in Dermatomyositis
inferred← citeshttps://doi.org/10.1007/s11926-020-00909-4openalex-snapshot
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics
inferred← citeshttps://doi.org/10.1007/s11926-022-01076-4openalex-snapshot
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis
inferred← citeshttps://doi.org/10.1007/s12016-009-8192-4openalex-snapshot
The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies
inferred← citeshttps://doi.org/10.1007/s12016-016-8527-xopenalex-snapshot
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review
inferred← citeshttps://doi.org/10.1007/s12016-020-08798-2openalex-snapshot
Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
inferred← citeshttps://doi.org/10.1007/s12519-019-00313-8openalex-snapshot
Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment
inferred← citeshttps://doi.org/10.1007/s40265-014-0240-6openalex-snapshot
Innate Immune-Response Mechanisms in Dermatomyositis: An Update on Pathogenesis, Diagnosis and Treatment
inferred← citeshttps://doi.org/10.1007/s40674-021-00182-1openalex-snapshot
Inhibiting Interferon Pathways in Dermatomyositis: Rationale and Preliminary Evidence
inferred← citeshttps://doi.org/10.1016/b978-0-12-417044-5.00042-1openalex-snapshot
Juvenile Dermatomyositis and Other Inflammatory Myopathies in Children
inferred← citeshttps://doi.org/10.1016/b978-0-323-24145-8.00026-0openalex-snapshot
Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1016/b978-0-443-11980-4.00030-1openalex-snapshot
Juvenile Dermatomyositis and Other Inflammatory Muscle Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-444-59565-2.00014-9openalex-snapshot
Juvenile dermatomyositis
inferred← citeshttps://doi.org/10.1016/b978-1-4160-6581-4.10024-xopenalex-snapshot
JUVENILE DERMATOMYOSITIS
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0435-8.00090-1openalex-snapshot
Inflammatory Myopathies
inferred← citeshttps://doi.org/10.1016/j.ajpath.2012.08.033openalex-snapshot
Immune-Mediated Necrotizing Myopathy Is Characterized by a Specific Th1-M1 Polarized Immune Profile
inferred← citeshttps://doi.org/10.1016/j.autrev.2026.104083openalex-snapshot
Long-term outcomes and prognostic factors in juvenile dermatomyositis: A systematic review of studies with more than 12 months of follow-up
inferred← citeshttps://doi.org/10.1016/j.bbadis.2014.05.034openalex-snapshot
Dermatomyositis, polymyositis and immune-mediated necrotising myopathies
inferred← citeshttps://doi.org/10.1016/j.cimid.2018.09.008openalex-snapshot
Immune response biomarkers in human and veterinary research
inferred← citeshttps://doi.org/10.1016/j.cyto.2014.02.002openalex-snapshot
Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: Implication for systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1016/j.cyto.2014.10.012openalex-snapshot
Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1016/j.gene.2015.09.058openalex-snapshot
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases
inferred← citeshttps://doi.org/10.1016/j.imlet.2017.10.011openalex-snapshot
Targeting interferons as a strategy for systemic sclerosis treatment
inferred← citeshttps://doi.org/10.1016/j.immuni.2024.09.004openalex-snapshot
Type I IFN drives unconventional IL-1β secretion in lupus monocytes
inferred← citeshttps://doi.org/10.1016/j.injr.2013.09.006openalex-snapshot
Pathogenesis of myositis: Lessons learned from animal studies
inferred← citeshttps://doi.org/10.1016/j.jaut.2022.102979openalex-snapshot
The complement system and human autoimmune diseases
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2021.10.003openalex-snapshot
Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies
inferred← citeshttps://doi.org/10.1016/j.jid.2021.11.031openalex-snapshot
Type I Interferons in Autoimmunity
inferred← citeshttps://doi.org/10.1016/j.jns.2011.09.032openalex-snapshot
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
inferred← citeshttps://doi.org/10.1016/j.jpeds.2010.04.034openalex-snapshot
Gene-Gene-Sex Interaction in Cytokine Gene Polymorphisms Revealed by Serum Interferon Alpha Phenotype in Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1016/j.nmd.2021.08.007openalex-snapshot
Inflammatory myopathies in childhood
inferred← citeshttps://doi.org/10.1016/j.prrv.2026.03.001openalex-snapshot
Immunomodulation in paediatric inflammatory interstitial lung diseases: towards mechanism-based targeted therapies, a focus on the anti-cytokines
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2024.152426openalex-snapshot
Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature
inferred← citeshttps://doi.org/10.1016/j.talanta.2021.122338openalex-snapshot
Selective analysis of interferon-alpha in human serum with boronate affinity oriented imprinting based plastic antibody
inferred← citeshttps://doi.org/10.1016/s2665-9913(21)00254-xopenalex-snapshot
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease
inferred← citeshttps://doi.org/10.1021/acscombsci.0c00108openalex-snapshot
An Aptamer Linked Immobilized Sorbent Assay (ALISA) to Detect Circulatory IFN-α, an Inflammatory Protein among Tuberculosis Patients
inferred← citeshttps://doi.org/10.1038/nrrheum.2018.31openalex-snapshot
Type I interferon in rheumatic diseases
inferred← citeshttps://doi.org/10.1038/s41420-024-02194-xopenalex-snapshot
Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene
inferred← citeshttps://doi.org/10.1080/1744666x.2021.1939686openalex-snapshot
Type I interferon detection in autoimmune diseases: challenges and clinical applications
inferred← citeshttps://doi.org/10.1084/jem.20161451openalex-snapshot
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
inferred← citeshttps://doi.org/10.1089/dna.2018.4256openalex-snapshot
Discovery of Key Genes in Dermatomyositis Based on the Gene Expression Omnibus Database
inferred← citeshttps://doi.org/10.1089/jir.2011.0071openalex-snapshot
Interferon Alpha as a Primary Pathogenic Factor in Human Lupus
inferred← citeshttps://doi.org/10.1093/brain/awy105openalex-snapshot
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
inferred← citeshttps://doi.org/10.1093/rheumatology/keac404openalex-snapshot
Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1093/rheumatology/kead186openalex-snapshot
Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis
inferred← citeshttps://doi.org/10.1093/rheumatology/kew213openalex-snapshot
Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients
inferred← citeshttps://doi.org/10.1093/rheumatology/kew431openalex-snapshot
Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
inferred← citeshttps://doi.org/10.1093/rheumatology/kez525openalex-snapshot
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling
inferred← citeshttps://doi.org/10.1097/bor.0000000000000103openalex-snapshot
Recent advances in juvenile idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1097/bor.0000000000000540openalex-snapshot
Dermatomyositis etiopathogenesis: a rebel soldier in the muscle
inferred← citeshttps://doi.org/10.1097/bor.0000000000000653openalex-snapshot
Interferon-signature in idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1097/bor.0000000000000816openalex-snapshot
Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy
inferred← citeshttps://doi.org/10.1097/bor.0b013e3283317b31openalex-snapshot
Role of cytokines and chemokines in idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1101/2023.08.03.551696openalex-snapshot
An unconventional mechanism of IL-1β secretion that requires Type I IFN in lupus monocytes
inferred← citeshttps://doi.org/10.1111/exd.14043openalex-snapshot
Increased expression of TLR7 and TLR9 in alopecia areata
inferred← citeshttps://doi.org/10.1111/j.1365-2249.2011.04533.xopenalex-snapshot
Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1
inferred← citeshttps://doi.org/10.1111/j.1525-1470.2011.01501.xopenalex-snapshot
Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis‐Specific Autoantibodies, and Review of Rituximab Use
inferred← citeshttps://doi.org/10.1111/sji.12449openalex-snapshot
Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies
inferred← citeshttps://doi.org/10.1136/annrheumdis-2011-200463openalex-snapshot
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1136/annrheumdis-2012-201849openalex-snapshot
Low serum levels of vitamin D in idiopathic inflammatory myopathies
inferred← citeshttps://doi.org/10.1136/annrheumdis-2012-202024openalex-snapshot
Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients
inferred← citeshttps://doi.org/10.1136/ard.2010.139949openalex-snapshot
Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis
inferred← citeshttps://doi.org/10.1136/rmdopen-2022-002864openalex-snapshot
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
inferred← citeshttps://doi.org/10.1136/rmdopen-2022-002876openalex-snapshot
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
inferred← citeshttps://doi.org/10.1152/physrev.00047.2024openalex-snapshot
Type I interferons in health and disease: molecular aspects and clinical implications
inferred← citeshttps://doi.org/10.1155/2010/826434openalex-snapshot
Promoter Variant ofPIK3C3Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients
inferred← citeshttps://doi.org/10.1155/2012/682018openalex-snapshot
Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.1186/ar2885openalex-snapshot
Type 1 interferons and myositis
inferred← citeshttps://doi.org/10.1186/ar3150openalex-snapshot
Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance
inferred← citeshttps://doi.org/10.1186/ar3531openalex-snapshot
Type I interferon pathway in adult and juvenile dermatomyositis
inferred← citeshttps://doi.org/10.1186/s12969-017-0171-3openalex-snapshot
Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study
inferred← citeshttps://doi.org/10.1186/s12969-019-0361-2openalex-snapshot
Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon
inferred← citeshttps://doi.org/10.1186/s12969-021-00637-8openalex-snapshot
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
inferred← citeshttps://doi.org/10.1186/s13075-021-02665-xopenalex-snapshot
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM
inferred← citeshttps://doi.org/10.1186/s13578-023-01188-zopenalex-snapshot
The crucial regulatory role of type I interferon in inflammatory diseases
inferred← citeshttps://doi.org/10.1371/journal.pone.0029126openalex-snapshot
Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
inferred← citeshttps://doi.org/10.1371/journal.pone.0029161openalex-snapshot
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
inferred← citeshttps://doi.org/10.1371/journal.pone.0064376openalex-snapshot
Single Nucleotide Polymorphisms in the Tumor Necrosis Factor-Alpha Gene Promoter Region Alter the Risk of Psoriasis Vulgaris and Psoriatic Arthritis: A Meta-Analysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0092171openalex-snapshot
Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage
inferred← citeshttps://doi.org/10.1371/journal.pone.0102841openalex-snapshot
Associations between TNF-α-308A/G Polymorphism and Susceptibility with Dermatomyositis: A Meta-Analysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0260511openalex-snapshot
Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis
inferred← citeshttps://doi.org/10.14412/1995-4484-2020-214-224openalex-snapshot
EFFICACY AND SAFETY OF TOFACITINIB FOR IMMUNEMEDIATED INFLAMMATORY RHEUMATIC DISEASES (PART II)
inferred← citeshttps://doi.org/10.14740/jmc3940openalex-snapshot
A Continuous Increase in CXC-Motif Chemokine Ligand 10 in a Case of Anti-Nuclear Matrix Protein-2-Positive Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1542/peds.2010-3022openalex-snapshot
Familial Aggregation of Autoimmune Disease in Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.1590/s0482-50042010000300010openalex-snapshot
Dermatomiosite juvenil: revisão e atualização em patogênese e tratamento
inferred← citeshttps://doi.org/10.1684/ecn.2011.0285openalex-snapshot
Functional study of TNF-α promoter polymorphisms : literature review and meta-analysis
inferred← citeshttps://doi.org/10.2217/ijr.09.50openalex-snapshot
Clinical applications of IFN-α blockade in systemic lupus erythematosus
inferred← citeshttps://doi.org/10.3109/08916930903510872openalex-snapshot
Type I interferons in systemic autoimmunity
inferred← citeshttps://doi.org/10.3389/fimmu.2018.02951openalex-snapshot
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools
inferred← citeshttps://doi.org/10.3389/fimmu.2019.01028openalex-snapshot
Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.3389/fimmu.2020.593891openalex-snapshot
How Retroviruses and Retrotransposons in Our Genome May Contribute to Autoimmunity in Rheumatological Conditions
inferred← citeshttps://doi.org/10.3389/fimmu.2020.605087openalex-snapshot
Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue
inferred← citeshttps://doi.org/10.3389/fneur.2019.00554openalex-snapshot
Biomarkers in Inflammatory Myopathies—An Expanded Definition
inferred← citeshttps://doi.org/10.3389/fphar.2021.633821openalex-snapshot
Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
inferred← citeshttps://doi.org/10.3390/children11091046openalex-snapshot
Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review
inferred← citeshttps://doi.org/10.3390/ijms25137126openalex-snapshot
Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness
inferred← citeshttps://doi.org/10.3791/57421openalex-snapshot
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
inferred← citeshttps://doi.org/10.3899/jrheum.110590openalex-snapshot
The Autoimmune Disease Risk Allele of UBE2L3 in African American Patients with Systemic Lupus Erythematosus: A Recessive Effect Upon Subphenotypes
inferred← citeshttps://doi.org/10.3899/jrheum.121031openalex-snapshot
Longitudinal Peripheral Blood Lymphocyte Subsets Correlate with Decreased Disease Activity in Juvenile Dermatomyositis
inferred← citeshttps://doi.org/10.3899/jrheum.160293openalex-snapshot
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis
inferred← citeshttps://doi.org/10.3899/jrheum.180045openalex-snapshot
Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency
inferred← citeshttps://doi.org/10.4049/jimmunol.1100857openalex-snapshot
Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-α and Serologic Autoimmunity in Lupus Patients
inferred← citeshttps://doi.org/10.5772/55555openalex-snapshot
The Role of Type I IFN and TNF-α in the Pathogenesis of Sarcoidosis
inferred← citeshttps://doi.org/10.6084/m9.figshare.16681511openalex-snapshot
Additional file 1 of JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
inferred← citeshttps://doi.org/10.6084/m9.figshare.16681514openalex-snapshot
Additional file 2 of JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
inferred← citeshttps://doi.org/10.70675/149672f6zd66az455ezaf8dz5befec5c0dc5openalex-snapshot
Nouvelles immunothérapies dans le traitement du syndrome de Sjögren et autres maladies interféron-dépendantes
inferred← citeshttps://doi.org/10.70675/56be76a9z1a05z4438zabf7zaf769da7e2fcopenalex-snapshot
Clinical and molecular characterisation of type I interferonopathies
inferred← citeshttps://doi.org/10.70675/77959a81zcd04z45faz97e1ze254b7807703openalex-snapshot
Rôles des interférons dans la physiopathologie des myopathies inflammatoires
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.